With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.50982-12-2,Dichloro(cycloocta-1,5-diene)ruthenium(II),as a common compound, the synthetic route is as follows.
A mixture of (0421) [RuCl2(COD)]n (359 mg, 1.281 mmol), PPh3 (336 mg, 1.281 mmol) and ligand la (341 mg, 1.281 mmol) was stirred in THF (15 ml) at 75 C for 39 h in a KONTES pressure tube. After cooling down, the resulting brick precipitate was collected on a filter frit, washed with diethyl ether (3 >< 5 ml) and vacuum dried. Recrystallization from hot dichloromethane following layering with diethyl ether afforded analytically pure complex A-l in 29% yield (260 mg).
As the paragraph descriping shows that 50982-12-2 is playing an increasingly important role.
Reference£º
Patent; LOS ALAMOS NATIONAL SECURITY, LLC; DUB, Pavel, A.; GORDON, John, Cameron; WO2015/191505; (2015); A1;,
Highly efficient and robust molecular ruthenium catalysts for water oxidation
Catalysts | Special Issue : Ruthenium Catalysts – MDPI